Clinical endpoints in transcatheter aortic valve implantation: A call to ARC for standardised definitions

EuroIntervention

Volumn 5, Issue 1, 2009, Pages 29-31

  Piazza, Nicolo ^a   Cutlip, Donald E ^b   Onuma, Yoshinobu ^a   Kappetein, Arie Pieter ^a   de Jaegere, Peter ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; EDITORIAL; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MORBIDITY; MORTALITY; PATIENT SAFETY; PRACTICE GUIDELINE; RETREATMENT; STANDARDIZATION; TREATMENT OUTCOME;

EID: 77953672037     PISSN: 1774024X     EISSN: None     Source Type: Journal    
DOI: 10.4244/EIJV5I1A5     Document Type: Editorial

References (13)

1. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. Journal of the American College of Cardiology 2006; 47(6):1214-1223.
2. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116(7):755-763.
3. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW. Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study. Circulation 2006; 114(15):1616-1624.
4. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. Journal of the American College of Cardiology 2007; 50(1):69-76.
5. Schofer J, Schluter M, Treede H, Franzen OW, Tubler T, Pascotto A, Low RI, Bolling SF, Meinertz T, Reichenspurner H. Retrograde Transarterial Implantation of a Nonmetallic Aortic Valve Prosthesis in High-Surgical-Risk Patients with Severe Aortic Stenosis. A First-in-Man Feasibility and Safety Study. Circ Cardiovasc Intervent 2008;1:126-133.
6. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve ReValving System - Results from the Multicenter, Expanded Evaluation Registry 1-year following CE mark approval. EuroIntervention 2008; (4):242-249.
7. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System. Circ Cardiovasc Intervent 2008; 1(3):167-175.
8. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 2008; 4(2):193-199.
9. Rosengart TK, Feldman T, Borger MA, Vassiliades TA, Jr., Gillinov AM, Hoercher KJ, Vahanian A, Bonow RO, O'Neill W. Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2008; 117(13):1750-1767.
10. Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 2008; 85(4):1490-1495.
11. Piazza N, Onuma Y, de Jaegere P, Serruys PW. Guidelines for reporting mortality and morbidity after cardiac valve interventions - need for a reappraisal? Ann Thorac Surg 2009; 87(2):357-358; discussion 359-360.
12. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115(17):2344-2351.
13. Serruys P. Keynote Address - EuroPCR 2008, Barcelona, May 14th, 2008 Transcatheter aortic valve implantation: state of the art. EuroIntervention 2009;4:558-565.